Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2388048rdf:typepubmed:Citationlld:pubmed
pubmed-article:2388048lifeskim:mentionsumls-concept:C0019169lld:lifeskim
pubmed-article:2388048lifeskim:mentionsumls-concept:C0019171lld:lifeskim
pubmed-article:2388048lifeskim:mentionsumls-concept:C0037140lld:lifeskim
pubmed-article:2388048lifeskim:mentionsumls-concept:C0003451lld:lifeskim
pubmed-article:2388048lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:2388048lifeskim:mentionsumls-concept:C0524909lld:lifeskim
pubmed-article:2388048lifeskim:mentionsumls-concept:C0679199lld:lifeskim
pubmed-article:2388048lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:2388048pubmed:issue2lld:pubmed
pubmed-article:2388048pubmed:dateCreated1990-9-27lld:pubmed
pubmed-article:2388048pubmed:abstractTextPrimary duck hepatocyte (PDH) cultures were established from ducklings congenitally infected with the duck hepatitis B virus (DHBV), plated onto feeder cell layers of irradiated human embryonic lung fibroblasts, and observed for 2 to 3 weeks. This system permitted the survival of the PDH in a differentiated form free of fibroblastic overgrowth for at least 3 weeks. The hepatocytes were shown to contain all the replicative DNA intermediates found during DHBV replication as well as the DHBV structural proteins PRE-S1, PRE-S2, and S of duck hepatitis B surface antigen (DHBsAg). The pool of supercoiled (SC) DHBV DNA increased dramatically from days 10 to 14 postplating. This PDH-feeder cell layer cell culture model provides a convenient system to study the effects of conventional inhibitors of DHBV replication and compounds targeted at the supercoiled form of DHBV DNA. This approach should allow the evaluation of a variety of strategies for treating chronic carriers of hepadnaviruses.lld:pubmed
pubmed-article:2388048pubmed:languageenglld:pubmed
pubmed-article:2388048pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2388048pubmed:citationSubsetIMlld:pubmed
pubmed-article:2388048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2388048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2388048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2388048pubmed:statusMEDLINElld:pubmed
pubmed-article:2388048pubmed:monthJunlld:pubmed
pubmed-article:2388048pubmed:issn0146-6615lld:pubmed
pubmed-article:2388048pubmed:authorpubmed-author:WangY YYYlld:pubmed
pubmed-article:2388048pubmed:authorpubmed-author:GussHHlld:pubmed
pubmed-article:2388048pubmed:authorpubmed-author:BirchCClld:pubmed
pubmed-article:2388048pubmed:authorpubmed-author:BishopNNlld:pubmed
pubmed-article:2388048pubmed:authorpubmed-author:LocarniniSSlld:pubmed
pubmed-article:2388048pubmed:authorpubmed-author:CiviticoGGlld:pubmed
pubmed-article:2388048pubmed:authorpubmed-author:GuoK JKJlld:pubmed
pubmed-article:2388048pubmed:issnTypePrintlld:pubmed
pubmed-article:2388048pubmed:volume31lld:pubmed
pubmed-article:2388048pubmed:ownerNLMlld:pubmed
pubmed-article:2388048pubmed:authorsCompleteYlld:pubmed
pubmed-article:2388048pubmed:pagination82-9lld:pubmed
pubmed-article:2388048pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:meshHeadingpubmed-meshheading:2388048-...lld:pubmed
pubmed-article:2388048pubmed:year1990lld:pubmed
pubmed-article:2388048pubmed:articleTitleAntiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus model.lld:pubmed
pubmed-article:2388048pubmed:affiliationHepatitis Research Unit, Macfarlane Burnet Centre for Medical Research, Fairfield Hospital, Victoria, Australia.lld:pubmed
pubmed-article:2388048pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2388048pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2388048lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2388048lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2388048lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2388048lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2388048lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2388048lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2388048lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2388048lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2388048lld:pubmed